Abstract:Background Acute kidney injury (AKI) is a major risk factor for chronic kidney disease and increased mortality. Until now, no compelling preventive or therapeutic strategies have been identified. Dietary interventions have been proven highly effective in organ protection from ischemia reperfusion injury in mice and restricting dietary intake of sulfur‐containing amino acids (SAA) seems to be instrumental in this regard. The UNICORN trial aimed to evaluate the protective impact of restricting SAA intake before cardiac surgery on incidence of AKI. Methods and Results In this single‐center, randomized, controlled, double‐blind trial, 115 patients were assigned to a SAA‐reduced formula diet (LowS group) or a regular formula diet (control group) in a 1:1 ratio for 7 days before scheduled cardiac surgery. The primary end point was incidence of AKI within 72 hours after surgery, secondary end points included increase of serum creatinine at 24, 48, and 72 hours as well as safety parameters. Quantitative variables were analyzed with nonparametric methods, while categorical variables were evaluated by means of Chi‐square or Fisher test. SAA intake in the group with SAA reduced formula diet was successfully reduced by 77% (group with SAA reduced formula diet, 7.37[6.40–7.80] mg/kg per day versus control group, 32.33 [28.92–33.60] mg/kg per day, P <0.001) leading to significantly lower serum levels of methionine. No beneficial effects of SAA restriction on the rate of AKI after surgery could be observed (group with SAA reduced formula diet, 23% versus control group, 16%; P =0.38). Likewise, no differences were recorded with respect to secondary end points (AKI during hospitalization, creatinine at 24, 48, 72 hours after surgery) as well as in subgroup analysis focusing on age, sex, body mass index and diabetes. Conclusions SAA restriction was feasible in the clinical setting but was not associated with protective properties in AKI upon cardiac surgery. Registration URL: https://www.clinicaltrials.gov; Unique Identifier: NCT03715868. Nonstandard Abbreviations and Acronyms AKI acute kidney injury CG control group CR calorie restriction IGFBP7 Insulin Like Growth Factor Binding Protein 7 SAA sulfur‐containing amino acids TIMP‐2 Tissue inhibitor of metalloproteinases 2 TSP transsulfuration pathway Clinical Perspective What Is New? To our knowledge, the UNICORN trial is the first study assessing the potential benefit of restricting sulfur‐containing amino acids for organ protection in humans. In this single‐center, randomized, controlled, double‐blind trial a 7‐day restriction of sulfur‐containing amino acids did not ameliorate acute kidney injury after cardiac surgery. What Are the Clinical Implications? A deeper mechanistic insight is necessary to translate the findings elicited by cysteine and methionine restriction in animals into the human setting. As this study cannot report a beneficial effect of restriction of sulfur‐containing amino acids on acute kidney injury in humans, further studies should rather focus on pharmacological approaches that activate underlying, evolutionary conserved mechanisms of enhanced stress resistance. With an incidence of up to 40%, acute kidney injury (AKI) is a frequently encountered complication after cardiac surgery. 1 , 2 , 3 Even mild cases are associated with a longer hospital stay, higher morbidity, and increased short‐term as well as long‐term mortality. 4 , 5 , 6 Despite several clinical trials using pharmacological agents, the quest for an effective reno‐protective treatment has not been successful to date. 1 In recent years, promising and innovative nonpharmacological strategies to enhance cellular resilience have emerged—remote ischemic preconditioning being the mos -Abstract Truncated-

Amino Acid Infusion to Protect Kidney Function after Cardiac Surgery

A Randomized Trial of Intravenous Amino Acids for Kidney Protection.

Amino Acid Transport in Mammalian Oocytes

Improvement of Cardiac Function after Coronary Artery Bypass Grafting Surgery Reduces the Risk of Postoperative Acute Kidney Injury

Amino Acid Infusion for Perioperative Functional Renal Protection: A Meta-analysis

Amino acids to prevent cardiac surgery-associated acute kidney injury: a randomized controlled trial

Amino Acids’ Protective Effects on Experimental Acute Renal Failure

A Double-Blinded, Randomized, Placebo-Controlled Clinical Trial of Aminophylline to Prevent Acute Kidney Injury in Children Following Congenital Heart Surgery With Cardiopulmonary Bypass

Intravenous amino acid therapy for kidney function in critically ill patients: a randomized controlled trial

Preoperative Short‐Term Restriction of Sulfur‐Containing Amino Acid Intake for Prevention of Acute Kidney Injury After Cardiac Surgery: A Randomized, Controlled, Double‐Blind, Translational Trial

Amino Acids Protects Against Renal Ischemia-Reperfusion Injury and Attenuates Renal Endothelin.1 Disorder in Rats

Clinical Study of the Protective Effect of Exogenous Creatine Phosphate on Ischemic Myocardium During Open Heart Surgery

Proteome Analysis of Renoprotection Mediated by a Novel Cyclic Helix B Peptide in Acute Kidney Injury

Lysosomal autophagia in experimental nonoliguric acute renal failure and protect ion by amino acids in rats

Effects of preoperative high-oral protein loading on short- and long-term renal outcomes following cardiac surgery: a cohort study

The Effect of IV Amino Acid Supplementation on Mortality in ICU Patients May Be Dependent on Kidney Function: Post Hoc Subgroup Analyses of a Multicenter Randomized Trial

Strategies for post–cardiac surgery acute kidney injury prevention: A network meta-analysis of randomized controlled trials

Renal Function Improvement Following ANG-3777 Treatment in Patients at High Risk for Delayed Graft Function After Kidney Transplantation

Protection of kidney function and tissue integrity by pharmacologic use of natriuretic peptides and neprilysin inhibitors

Effect of intraoperative amino acid infusion on postoperative liver and renal function in elderly patients undergoing gastrointestinal surgery

Postoperative 20% Albumin and Cardiac Surgery Associated Kidney Injury, Statistical Analysis Plan and Updated Protocol